$BURU What's Driving the PPS Upward?
• Major Backlog Injection: Tekne brings approximately $135.4 million in un-audited net remaining order value. For a micro-cap company like NUBURU that recently reported low quarterly revenues ($524K), integrating an asset with this depth of signed contracts can fundamentally rewrite its valuation metrics.
• No Imminent Dilution: NUBURU confirmed that the cash required to close the acquisition is already fully secured from its prior public offerings. They do not need to execute an immediate capital raise or issue new dilutive shares to finalize the transaction.
• Clearance Achieved: The biggest hurdle—the Italian Government’s Golden Power authorization—was already approved. The October 15 deadline is mostly for notarial formalities and final paperwork
• Major Backlog Injection: Tekne brings approximately $135.4 million in un-audited net remaining order value. For a micro-cap company like NUBURU that recently reported low quarterly revenues ($524K), integrating an asset with this depth of signed contracts can fundamentally rewrite its valuation metrics.
• No Imminent Dilution: NUBURU confirmed that the cash required to close the acquisition is already fully secured from its prior public offerings. They do not need to execute an immediate capital raise or issue new dilutive shares to finalize the transaction.
• Clearance Achieved: The biggest hurdle—the Italian Government’s Golden Power authorization—was already approved. The October 15 deadline is mostly for notarial formalities and final paperwork
